Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$11.35
0.131.16%
Pre-Market: 7:00 AM EDT
Comments
Loading...
Keros Therapeutics (KROS) Forecast
NewsEarningsKeros Therapeutics (KROS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Keros Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KROS | Benzinga
Explore Keros Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KROS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Keros Therapeutics (KROS) stock?
You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.
Who are Keros Therapeutics (KROS) competitors?
Other companies in Keros Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Keros Therapeutics (KROS) stock?
Keros Therapeutics has a consensus price target of $34.88.
What is the current price for Keros Therapeutics (KROS)?
The stock price for Keros Therapeutics (NASDAQ: KROS) is $11.35 last updated March 24, 2025 at 7:00 AM EDT.
Does Keros Therapeutics (KROS) pay a dividend?
There are no upcoming dividends for Keros Therapeutics.
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Keros Therapeutics (KROS) going to split?
There is no upcoming split for Keros Therapeutics.
What sector and industry does Keros Therapeutics (KROS) operate in?
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.